Dark
Light
System
Security
Catabasis Pharmaceuticals Inc
Catabasis Pharmaceuticals Inc . Institutional holdings reported to the SEC.

Institutional Holders (2015Q2)
Portfolio Summary: 21 Institutional holders with a total value of $129,026,000.
#
Manager Name
Shares
Value ($)
%
Options
Notes
1 SV Health Investors, LLC 2,857,667 34,892,000 27.04%
2 Clarus Ventures, LLC 2,752,488 33,608,000 26.05%
3 FMR LLC 1,455,718 17,774,000 13.78%
4 Camber Capital Management LP 927,609 11,326,000 8.78%
5 DEERFIELD MANAGEMENT COMPANY, L.P. 738,055 9,012,000 6.98%
6 SPHERA FUNDS MANAGEMENT LTD. 446,036 5,060,000 3.92%
7 WELLINGTON MANAGEMENT GROUP LLP 305,137 3,726,000 2.89%
8 Rhenman & Partners Asset Management AB 265,427 3,241,000 2.51%
9 BVF INC/IL 225,000 2,747,000 2.13%
10 PUTNAM INVESTMENTS LLC 148,131 1,809,000 1.40%
11 VANGUARD GROUP INC 88,000 1,074,000 0.83%
12 MONASHEE INVESTMENT MANAGEMENT LLC 80,000 977,000 0.76% PRN
13 MILLENNIUM MANAGEMENT LLC 74,791 913,000 0.71%
14 FEDERATED HERMES, INC. 50,000 611,000 0.47%
15 Alyeska Investment Group, L.P. 50,000 611,000 0.47%
16 Clearline Capital LP 46,796 571,000 0.44%
17 NORGES BANK 40,000 488,000 0.38%
18 GOLDMAN SACHS GROUP INC 25,000 305,000 0.24%
19 FRED ALGER MANAGEMENT, LLC 20,000 244,000 0.19%
20 DEUTSCHE BANK AG\ 2,400 29,000 0.02%
21 Tower Research Capital LLC (TRC) 648 8,000 0.01%

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.